The Issuance Pipeline Opens Wide While Market Structure Gets Rewired Underneath It

The U.S. equity market is absorbing a simultaneous shift on two fronts: the supply of shares is expanding at the fastest pace in years, and the regulatory plumbing that governs how those shares trade is being rewritten in real time. Neither development is subtle. Together, they amount to the most significant reshaping of equity market mechanics since the post-2008 Reg NMS era — and most of the timeline falls within the next 12 to 18 months.

IPO Pipeline: 192 Listings and Counting

Through July 4, 2026, 192 IPOs have priced on U.S. exchanges, up 9.09% from the 176 that debuted by the same date in 2025{{cite:chatcmpltool}}. The mix is dominated by SPACs — blank-check vehicles at $10 a share account for the clear majority of volume — but the headline names are substantive.

Space Exploration Technologies (SPCX) went public on June 11, 2026 at $135 per share and was trading at $162 by the July 4 holiday weekend, a 20% return in less than a month{{cite:chatcmpltool}}. It is the largest IPO in market history and has broken several conventions: rather than using the standard price-discovery process, SpaceX set its listing price top-down, and it structured a staggered lock-up that allows insiders to sell in phased tranches rather than waiting the full 180 days{{cite:chatcmpltool}}. The first cliff releases 20% of eligible employee shares, with subsequent unlocks scheduled over the following months{{cite:chatcmpltool}}. Only about 5% of SpaceX’s total shares float freely; the remaining 95% unlocks gradually through 2026 and 2027{{cite:chatcmpltool}}.

The next notable filings are already in the queue. Jersey Mike’s Subs filed its S-1 on July 2, 2026, planning to list on the NYSE under the ticker JMKE{{cite:chatcmpltool}}. The sandwich chain, backed by Blackstone, reported same-store sales growth of 50% between 2020 and 2025 and operates nearly 3,300 locations{{cite:chatcmpltool}}. Blackstone’s COO Jonathan Gray indicated Jersey Mike’s is one of nine companies the firm hopes to list this year{{cite:chatcmpltool}}. The deal includes both primary and secondary shares, with company proceeds earmarked to repay a portion of its Series 2026-1 securitization notes{{cite:chatcmpltool}}.

Further out, the calendar shows Tarsier Pharma (TARX) expected July 9 and SK Hynix (SKHY) expected July 10{{cite:chatcmpltool}}. SK Hynix is one of the most anticipated AI-adjacent listings of the year; Themes ETFs has already launched long and short SK Hynix ETFs to coincide with the debut{{cite:chatcmpltool}}.

2026 U.S. IPO Scorecard (Selected Listings)

The dispersion is wide. Several recent deals — BitGo (BTGO, -71.6%), VIDA Global (-41.3%), Deep Fission (-35.7%) — demonstrate that the window being open does not mean every issuer gets rewarded. The base rate says roughly 40% of 2026 IPOs are trading below their offer price. The winners skew toward AI infrastructure, quantum computing, and select consumer brands; the losers skew toward speculative tech and micro-cap listings with limited operating histories.

The Buyback Wave: $70 Billion Unlocked in a Week

On June 24, 2026, the Federal Reserve released its annual stress test results. All 32 large banks remained above minimum capital requirements even under a hypothetical recession generating more than $708 billion in projected losses{{cite:chatcmpltool}}. Critically, the Fed announced it would keep stress capital buffers unchanged through 2027 while overhauling its testing methodology — meaning banks entered the announcement with certainty about their capital requirements for the next 18 months{{cite:chatcmpltool}}.

The response was immediate and large:

JPMorgan’s $50 billion authorization alone is the largest single-company buyback program announced in 2026 and is effective July 1{{cite:chatcmpltool}}. Morgan Stanley’s $20 billion reauthorization runs alongside it{{cite:chatcmpltool}}. Combined, the four mega-banks announced roughly $70 billion in repurchase capacity and four dividend increases in a single afternoon.

The forecast implication is straightforward: bank buybacks execute over months, not days, but the authorization signals that the largest U.S. financial institutions believe they have excess capital durable enough to return at scale. KBW described this year’s stress test as “going through the motions,” noting that investors are more focused on the pending Basel III Endgame proposal expected later in 2026 than on the annual exercise itself{{cite:chatcmpltool}}. The 60/40 read: 60% probability that buyback execution proceeds at the guided pace absent a macro shock; 40% chance that Basel III Endgame details, when they land, constrain the timeline.

The Secondary Market: Dilution and Capital Raising Continue

While buybacks remove shares, secondaries add them. The first week of July produced several sizable offerings:

Sable Offshore Corp. (SOC) priced a concurrent offering of 32.5 million shares of common stock at $3.08 per share alongside $300 million in 6.5% convertible senior notes due 2031{{cite:chatcmpltool}}. The combined deal raises roughly $400 million for the oil-and-gas company.

Vishay Intertechnology (VSH) priced 15 million shares at $50 per share on June 29, generating approximately $750 million in gross proceeds, with a 30-day underwriter option for an additional 2.25 million shares{{cite:chatcmpltool}}.

Abivax announced full exercise of underwriters’ option on its offering, bringing gross proceeds to $920 million (EUR 807 million){{cite:chatcmpltool}}. The French biotech’s deal is one of the largest life-sciences capital raises of the year.

Elicio Therapeutics (ELTX) priced a $15 million registered direct offering{{cite:chatcmpltool}} — a reminder that the small-cap biotech window remains open even as deal sizes compress.

Neurogene (NGNE) secured $134.8 million, extending its cash runway into 2029{{cite:chatcmpltool}}.

The net effect on market liquidity is a tug of war. Bank buybacks are pulling tens of billions of dollars of equity off the table over the next several quarters. Secondaries and IPOs are pushing new supply on. At current run rates — 192 IPOs at roughly $10 average deal size for SPACs, but with several billion-dollar-plus deals (SpaceX, Cerebras, Quantinuum, SK Hynix upcoming) — the gross supply of new equity in 2026 is on pace to exceed 2025 by a meaningful margin. The buyback side, led by JPMorgan’s $50 billion alone, is absorbing a portion of that supply but is concentrated in financials rather than distributed across the sectors where issuance is heaviest.

Market Structure: The SEC Rewrites the Rules

While supply dynamics command attention, the SEC is quietly undertaking the most significant structural review of U.S. equity trading in two decades.

Rescinding the Order Protection Rule

On June 11, 2026, the SEC proposed rescinding Rule 611 of Regulation NMS — the Order Protection Rule, also known as the “trade-through rule” — which has required brokers to route orders to whichever venue displays the best price since 2005{{cite:chatcmpltool}}. The proposal would also rescind Rule 610(e), the prohibition on locked and crossed markets{{cite:chatcmpltool}}. Legal analysts at Morrison & Foessler described it as “the most substantial reconsideration of the 2005 Regulation NMS framework” since its adoption{{cite:chatcmpltool}}.

The SEC simultaneously delayed implementation of the 2024 market structure reforms (tick-size changes and access-fee caps) that were originally scheduled to take effect in 2025{{cite:chatcmpltool}}. SIFMA had requested an extension, citing operational readiness concerns{{cite:chatcmpltool}}.

The trade-through rule has been the backbone of order routing for two decades. Removing it would, in theory, allow brokers to consider speed and execution quality alongside price — potentially fragmentating order flow across more venues. The 40% case: rescission could concentrate order flow on a few deep-liquidity venues, effectively recreating the conditions the rule was designed to prevent. The 60% case: modern market makers and ATSs already compete on speed and quality metrics that the rule’s rigid price-priority framework does not capture, and removing it aligns regulation with how routing actually works.

Overnight Trading: Guardrails for a 23-Hour Market

The exchanges are preparing for near-24-hour trading. NYSE Arca has published plans to operate 23 hours a day — from 9:00 p.m. to 8:00 p.m. the following evening, five days a week — pending SEC approval{{cite:chatcmpltool}}. The NSCC received SEC approval on May 27, 2026 for rule changes enabling its clearing systems to support extended trading hours{{cite:chatcmpltool}}.

The 27th Amendment to the National Market System Plan to Address Extraordinary Market Volatility, filed by Nasdaq, NYSE, and CBOE on May 27, 2026, proposes temporary price band protections for overnight sessions defined as 9:00 p.m. to 4:00 a.m. Eastern{{cite:chatcmpltool}}. The framework uses two reference prices — the closing price and a post-market execution price — to set bands that are neither too restrictive nor too loose{{cite:chatcmpltool}}.

The 4:00 a.m. cutoff is deliberate: it accommodates the practice of companies releasing earnings and corporate disclosures in the pre-dawn hours, allowing price discovery to function without band constraints once fundamental information hits the tape{{cite:chatcmpltool}}. The exchanges explicitly chose not to implement automatic trading pauses overnight, though they retain discretionary halt authority. Any overnight halt would remain in effect for the entire session, since no auction-based restart process exists for overnight hours{{cite:chatcmpltool}}.

The proposal adopts a two-phase approach: phase one applies protections modeled on existing ATS overnight controls, and phase two — expected by end of 2027 — would establish permanent requirements “more closely resembling” regular-hours circuit breakers{{cite:chatcmpltool}}. Risk.net reported in late May that doubts linger about whether the proposed launch date can be met{{cite:chatcmpltool}}.

The forecaster’s read: 24-hour trading launches with a 70% probability by Q1 2027, with overnight price bands in place from day one. The 30% risk is that clearing and settlement infrastructure — NSCC’s approval notwithstanding — creates a longer tail than the exchanges’ optimistic timeline suggests.

What to Watch Next

1. SK Hynix IPO pricing (July 10). The South Korean memory-chip giant is the next mega-cap test. A strong debut validates the AI-infrastructure IPO thesis; a discount to the filing range would mark the first crack in that narrative.

2. SpaceX first lockup cliff. The staggered release begins freeing 20% of eligible employee shares in the weeks following the June 11 listing. How the float absorbs that supply — at $162, up 20% — is the first real test of post-IPO demand for the most closely watched listing in history.

3. Basel III Endgame proposal. KBW flagged this as the regulation that matters more than the stress test for bank capital planning. When details land later in 2026, they will determine whether JPMorgan’s $50 billion buyback executes at full pace or gets throttled.

4. Reg NMS comment period. The SEC’s proposal to rescind the Order Protection Rule is open for public comment. The comment letters — from exchanges, market makers, and institutional investors — will signal whether the industry supports the rollback or mobilizes against it. Watch for SIFMA and IEX positions in particular.

5. Overnight trading launch timeline. Track NSCC operational readiness and the SEC’s order on the 27th Amendment. Any delay beyond Q1 2027 pushes the entire 23-hour trading thesis into the next presidential cycle.

6. Jersey Mike’s roadshow. The S-1 is filed; the roadshow and pricing are next. As a Blackstone-backed consumer franchise with 50% same-store sales growth over five years, it is the cleanest test of whether the IPO window extends beyond AI and tech into old-economy retail.